Table 1.

Invasive fungal infections (IFIs) in patients with SARS-CoV-2 infection admitted to the Infectious Diseases Unit (IDU) of the University Hospital “Federico II” of Naples from the 8 March 2020 to the 1 July 2021.

Patient	Age, Years	Gender	Lenght of Stay, Days	Clinical Severity (8-Point WHO-OS) at IFI Diagnosis	Fungus	Diagnosis	Days Since Hospital Admission	ICU Admission Prior to IFI	Lenght of ICU Stay Prior to IFI, Days	Days Since COVID-19 Onset	Steroid Duration Prior to IFI, Days	Cumulative Steroid Dose (Prednisone Equivalent) Prior to IFI, mg	Lymphocytes Count, n/µL	CD4+ Count, n/µL	Outcome
1	75	M	121	4	Candida albicans	Proven	36	No	n/a	37	37	327	430	192	Recovery
				4	Candida parapsilosis		94	Yes	2	95	95	447	870	356
				4	Trichosporon asahii
2	75	M	31	5	Candida albicans	Proven	15	No	n/a	13	n/a	n/a	540	n/a	Death
3	86	F	54	5	Candida glabrata	Proven	46	Yes	2	52	53	1433	3920	n/a	Death
4	69	M	38	5	Candida albicans	Proven	8	No	n/a	11	10	586	800	n/a	Recovery
5	38	F	22	5	Candida parapsilosis	Proven	13	Yes	9	11	n/a	n/a	3660	n/a	Recovery
6	63	M	77	6	Aspergillus spp.	Probable	7	Yes	2	13	13	440	900	648	Death
7	79	M	41	4	Aspergillus fumigatus	Proven	5	No	n/a	65	60	1785	560	140	Recovery
				4	Pneumocystis jirovecii
8	63	F	78	4	Pneumocystis jirovecii	Proven	18	No	n/a	120	15	630	240	93	Recovery
9	52	M	18	4	Pneumocystis jirovecii	Proven	39	No	n/a	40	32	963	1260	895	Recovery
10	72	M	24	4	Pneumocystis jirovecii	Possible	15	No	n/a	26	20	475	2200	1012	Recovery
11	55	M	22	4	Pneumocystis jirovecii	Proven	3	No	n/a	45	15	400	260	62	Recovery
12	69	M	56	5	Pneumocystis jirovecii	Possible	28	Yes	15	39	25	1150	590	141	Recovery
13	31	F	62	6	Aspergillus fumigatus	Proven	8	Yes	5	11	8	853	860	n/a	Recovery
				6	Candida parapsilosis		31		28	34	31	n/a	720
				6	Pneumocystis jirovecii		48		45	51	48	3707	380